deflazacort oral suspension

Generic: deflazacort oral

Labeler: cranbury pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name deflazacort oral suspension
Generic Name deflazacort oral
Labeler cranbury pharmaceuticals, llc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

deflazacort 22.75 mg/mL

Manufacturer
Cranbury Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 27808-249
Product ID 27808-249_efc7fb53-ed0f-4ec1-a6ce-dee55f0064d1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217813
Listing Expiration 2026-12-31
Marketing Start 2024-05-01

Pharmacologic Class

Established (EPC)
corticosteroid [epc]
Mechanism of Action
corticosteroid hormone receptor agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 27808249
Hyphenated Format 27808-249

Supplemental Identifiers

RxCUI
1870964
UNII
KR5YZ6AE4B
NUI
N0000175576 N0000175450

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deflazacort oral suspension (source: ndc)
Generic Name deflazacort oral (source: ndc)
Application Number ANDA217813 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 22.75 mg/mL
source: ndc
Packaging
  • 13 mL in 1 BOTTLE (27808-249-01)
source: ndc

Packages (1)

27808-249-01 13 mL in 1 BOTTLE (27808-249-01)

Ingredients (1)

deflazacort (22.75 mg/mL)

Linked Drug Pages (1)

Deflazacort Oral Suspension ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "efc7fb53-ed0f-4ec1-a6ce-dee55f0064d1", "openfda": {"nui": ["N0000175576", "N0000175450"], "unii": ["KR5YZ6AE4B"], "rxcui": ["1870964"], "spl_set_id": ["881785a5-41b4-4679-a29b-5d77ca51ca60"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Cranbury Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "13 mL in 1 BOTTLE (27808-249-01)", "package_ndc": "27808-249-01", "marketing_start_date": "20240501"}], "brand_name": "Deflazacort Oral Suspension", "product_id": "27808-249_efc7fb53-ed0f-4ec1-a6ce-dee55f0064d1", "dosage_form": "SUSPENSION", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "27808-249", "generic_name": "Deflazacort Oral", "labeler_name": "Cranbury Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deflazacort Oral Suspension", "active_ingredients": [{"name": "DEFLAZACORT", "strength": "22.75 mg/mL"}], "application_number": "ANDA217813", "marketing_category": "ANDA", "marketing_start_date": "20240501", "listing_expiration_date": "20261231"}